Possible New Treatment for ANCA-Associated Vasculitis; Rituximab May Not Be Superior to Cyclophosphamide

Rituximab was found to be effective at inducing remission in two separate studies of severe antineutrophil cytoplasmic antibody–associated vasculitis reported in the July 15 issue of the New England Journal of Medicine.